Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
BioStem Technologies (BSEM) Stock Price & Analysis
58 Followers
BSEM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.18 - $15.50
Previous Close$9.11
Volume19.95K
Average Volume (3M)30.91K
Market Cap
$147.74M
Enterprise Value$153.52M
Total Cash (Recent Filing)$238.87K
Total Debt (Recent Filing)$5.78M
Price to Earnings (P/E)-20.5
Beta0.11
Next Earnings
May 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding9,240,583
10 Day Avg. Volume32,346
30 Day Avg. Volume30,907
Standard Deviation0.37
R-Squared0.05
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-13.12
Price to Sales (P/S)88.33
Price to Cash Flow (P/CF)1096.50
P/FCF Ratio147.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue56.93
Enterprise Value/Gross Profit122.64
Enterprise Value/Ebitda-99.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioStem Technologies News
BSEM FAQ
What was BioStem Technologies Inc’s price range in the past 12 months?
BioStem Technologies Inc lowest stock price was $1.18 and its highest was $15.50 in the past 12 months.
What is BioStem Technologies Inc’s market cap?
Currently, no data Available
When is BioStem Technologies Inc’s upcoming earnings report date?
BioStem Technologies Inc’s upcoming earnings report date is May 20, 2024 which is in 16 days.
How were BioStem Technologies Inc’s earnings last quarter?
BioStem Technologies Inc released its earnings results on Apr 01, 2024. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of $0.74 by -$0.92.
Is BioStem Technologies Inc overvalued?
According to Wall Street analysts BioStem Technologies Inc’s price is currently Overvalued.
Does BioStem Technologies Inc pay dividends?
BioStem Technologies Inc does not currently pay dividends.
What is BioStem Technologies Inc’s EPS estimate?
BioStem Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioStem Technologies Inc have?
BioStem Technologies Inc has 16,226,720 shares outstanding.
What happened to BioStem Technologies Inc’s price movement after its last earnings report?
BioStem Technologies Inc reported an EPS of -$0.18 in its last earnings report, missing expectations of $0.74. Following the earnings report the stock price went down -14.645%.
Which hedge fund is a major shareholder of BioStem Technologies Inc?
Currently, no hedge funds are holding shares in BSEM
---
BioStem Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.8%
Last 30 Days ▲ 8.7%
Last 30 Days ▲ 8.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
340.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
321.48%
Trailing 12-Months
Company Description
BioStem Technologies Inc
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on July 7, 2006 and is headquartered in Oakland Park, FL.
---
BSEM Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---